Latest filing published 08 Sept 2026 for Progyny, Inc., €122k. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Peter Anevski, listed as chief executive, appears in our data through filings on Progyny, Inc. shares, published by SEC (Form 4). In total, 86 filings cover trades dated from 3 May 2021 to 3 September 2026.
On the open market, the record shows 2 purchases worth €4.6M and 20 sales worth €13.3M. Sales outweigh purchases by €8.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 20 share grants and 36 option exercises.
The newest entry dates from 8 September 2026: a share grant of €122k, in Progyny, Inc. The last insider purchase was made public on 17 November 2025, 335 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 86 declarations